DCF — ST. BERNARDINE MEDICAL CENTER
Enterprise Value: $-491.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-491.0M
Enterprise Value
$-160.3M
PV of Cash Flows
$-330.6M
PV of Terminal Value
$-532.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $456.0M | $-27.9M | -6.0% | $-47.2M | $-42.9M |
| Year 2 | $469.7M | $-24.0M | -5.0% | $-43.9M | $-36.3M |
| Year 3 | $483.8M | $-19.9M | -4.0% | $-40.4M | $-30.3M |
| Year 4 | $498.3M | $-18.0M | -4.0% | $-39.1M | $-26.7M |
| Year 5 | $513.2M | $-17.2M | -3.0% | $-39.0M | $-24.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-491.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$442.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.06608662645305288
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5